PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia (Q35847727)
Jump to navigation
Jump to search
scientific article published on 18 January 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia |
scientific article published on 18 January 2005 |
Statements
1 reference
PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia (English)
1 reference
Nicholas C Wolff
1 reference
Darren R Veach
1 reference
William P Tong
1 reference
William G Bornmann
1 reference
Bayard Clarkson
1 reference
Robert L Ilaria
1 reference
18 January 2005
1 reference
1 reference
3995-4003
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference